AMR Centre News
Sign up for the AMR Centre Newsletter
Five professors honoured as Montreal ambassadors
McGill is the only organization with multiple Palais des congrès honourees
Read the article in the McGill Reporter
New funding to tackle antimicrobial resistance
Early career researcher Andréanne Lupien is part of a winning project in the 2024 McGill Innovation Fund competition.
Third running of the MIF turns focus to antimicrobial resistance
Innovation is alive and well at McGill! Six teams chosen from highly competitive field, as previous participants leverage their experience to secure their spot in new cohort.
MIF launches 3rd edition, offers new AMR award
The McGill Innovation Fund (MIF) is returning for a third edition and is partnering with the McGill AMR Centre to provide an additional $75,000 in funding to be distributed as a supplemental prize.
Getting things started at the McGill Antimicrobial Resistance Centre
RI-MUHC and McGill researchers join forces against a major global threat to human health. Mobilizing in the fight against antimicrobial resistance (AMR), researchers from the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University have launched a new intensive care unit platform for infection research, with scientific seminars and symposia, funding programs and much more.
MI4, Montreal’s powerhouse of infectious disease research, celebrates 5th anniversary
MI4 brings together over 250 researchers and 5,000 staff from a wide range of fields to find new solutions for some of humanity’s deadliest threats: tuberculosis, antimicrobial resistance, COVID-19 and many more. The group also studies immunity and how the immune system can be harnessed to fight infection. Today, MI4 has set its sights on a new global threat: antimicrobial resistance (AMR).
McGill AMR Researcher Andrew Gonzalez Makes the Highly Cited Researchers 2021 List
AMR member Andrew Gonzalez was one of 14 McGill scientists who made the 2021 list of most highly cited researchers. The list is compiled yearly by Clarivate and includes the top cited authors within their respective fields.
Stamping out superbugs
As the threat of the pandemic begins to fade in some areas, researchers are turning their attention to another imminent crisis: antimicrobial resistance.
Image by Owen Egan/Joni Dufour.
Diana Kwon | 24 Sep 2021
During the last year and a half, the world’s attention has been focused squarely on SARS-CoV-2, the coronavirus that causes COVID-19. While deadly, this virus is only one of many pathogens that threaten our well-being. For many years, scientists have been warning about another microscopic menace: drug-resistant microbes.
McGill University Health Centre Researcher Vivian Loo Receives the 2021 Peggy Lillis Foundation Innovator Award for Her Work With C.difficle
Clostridioides difficile causes approximately 500 000 infections a year in the United States most often developing following antibiotic treatment. As part of the US C.difficile Awareness month the Peggy Lillis Foundation held its virtual gala to raise awareness and recognize significant contributions in the field. One of three awardees was MUHC researcher Vivian Loo who received the Peggy Lillis Foundation Innovator Award.
McGill Researchers Solve the Largest Protein Crystal Structure Yet
AMR members Albert Berghuis and Martin Schmeing and their teams have recently solved the crystal structure of the Thermus thermophilus ribosome in complex with plazomicin at a resolution of 3.27 Å. The structure was recently reported in Nature Communications Biology.
Research Offers Insight in the Battle with Antibiotic Resistance
McGill researcher Albert Berghuis and his team reported structural details of EreC, an enzyme responsible for macrolide resistance. The structure was published in Nature Communications in March 2021.
New Antibiotic Resistance Centre Will Tackle Resistance Crisis
Antibiotic resistance is considered by the WHO to be one of the greatest threats facing mankind. With the creation of the Antimicrobial Research Centre, McGill Researchers will be at the forefront of the battle against antimicrobial resistance in microorganisms.